Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs

NCT: NCT06011551 · RECRUITING

NCT IDNCT06011551
StatusRECRUITING
Start Date2025-01-13
Completion2028-11

Brief Summary

A multi-center, prospective, dual arm, randomized, controlled pivotal study to evaluate the safety and effectiveness of the ReGelTec HYDRAFIL™ System.

Frequently Asked Questions

What is HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs?

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs is a clinical trial registered under NCT06011551. Current status: RECRUITING.

What is the status of NCT06011551?

The current status of NCT06011551 (HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs) is: RECRUITING.

When did HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs start?

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs started on 2025-01-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑